triangle

THANK YOU FOR YOUR INTEREST IN OUR NEW SERVICE

Whether you are conducting research in an academic laboratory or working in R&D for a pharmaceutical company, this is an important tool that may help you accelerate your discoveries involving Covid-19.

Working with collaborators and partners, Serimmune has processed and analyzed the epitope repertoires of over 15,000 subjects, including more than 1,000 SARS-CoV-2 samples.

Due to strong demand for access to the SERA technology to better understand the antibody response to SARS-CoV-2 vaccination and natural infection, Serimmune has launched a COVID epitope mapping discovery service.

triangle

How it Works

Customer Provides:

  • 50 ul of serum or plasma per sample
  • Minimal information about the samples

Serimmune:

Analyzes each sample for IgG antibodies using its 10 billion member, random 12mer, bacterial peptide display library

Analyzes each sample for IgG antibodies using its 10 billion member, random 12mer, bacterial peptide display library

Performs epitope analysis across the entire SARS-CoV-2 Proteome using its proprietary IMUNE and PIWAS methodologies

Performs epitope analysis across the entire SARS-CoV-2 Proteome using its proprietary IMUNE and PIWAS methodologies

Provides summary data and visualizations for each sample, including raw data for subsequent customer analysis

Provides summary data and visualizations for each sample, including raw data for subsequent customer analysis

triangle

For Each Sample the Customer Receives:

A composite score that compares the antibody epitopes identified in each sample to those observed in cohorts of individuals with mild, moderate and severe COVID-19 disease
A composite score that compares the antibody epitopes identified in each sample to those observed in cohorts of individuals with mild, moderate and severe COVID-19 disease
A list of motifs that are known to be enriched in SARS-CoV-2 positive subjects and the related enrichment scores in that sample
A list of motifs that are known to be enriched in SARS-CoV-2 positive subjects and the related enrichment scores in each sample
Samples are compared to both a healthy control as well as a COVID patient cohort and provided in an easy-to-interpret, interactive html format.
Samples are compared to both a pre-pandemic/healthy control as well as a COVID subject cohort and provided in an easy-to-interpret, interactive html format.
Raw data that includes Motifs with Enrichment Scores and IWAS values for each amino acid in the SARS-CoV-2 proteome to allow for more in-depth analysis by the customer.
Raw data that includes Motifs with Enrichment Scores and IWAS values for each amino acid in the SARS-CoV-2 proteome to allow for more in-depth analysis by the customer.
triangles

Two Different Business Models

To meet the needs of both our academic and biopharma customers we offer two different business models.


Data Sharing Model

Data Sharing Model<

For academic and medical research labs.

  • Customer provides minimal, de-identified information about the samples (e.g. sex, age, disease status).
  • Serimmune generates data and customer can use for its own purposes. Serimmune owns the data.
  • Significantly reduced price per sample.

Fee-For-Service Model

Fee-For-Service Model

For Industry partners including biopharma companies.

  • Customer sharing of information about the samples is optional.
  • Customer owns data and results.
  • Standard pricing.
triangle
How to Order